BioWorld Asia

March 11, 2009

Obama's Stem Cell Move Bolsters UK Companies

The news that President Obama is lifting the ban on federal funding was a boost for the UK's stem cell companies, with ReNeuron Group plc seeing its shares rise by 18 percent following the announcement. (BioWorld International) Read More

Roche, Evotec Collaborating in $300M Depression Drug

Mosquitoes' Immune Responses Could be Key to Malaria Control

Affitech, Pharmexa Combine Forces in Stock-Based Merger

Allergy Therapeutics Files for Pollinex Quattro OK

Europe Defends Science and Orphan Drugs

Genfit Broadens Scope of Sanofi Collaboration

Issues Facing Biotech, Pharma Converge to Boost M&A Activity

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 12, 2025.

AI-generated illustration of heart and metabolic impact

Deep Apple signs big Novo deal for cardiometabolic small molecules

BioWorld

Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an...

DNA double helix under a magnifying glass

23andme genetic privacy concerns garner Congressional scrutiny

BioWorld MedTech

The bankruptcy of genetic testing service 23andme Holding Corp. prompted a reaction from many quarters, but a June 11 Senate hearing highlighted an interest in...

3Sbio revs on with phase II data in tight PD-1/VEGF bispecific race

BioWorld

3Sbio Inc. reported interim phase II study results of its PD-1/VEGF bispecific antibody, SSGJ-707 – a “fabulous” asset, according to Pfizer Inc. CEO Albert...